S B Killick
- Outcome of biphenotypic acute leukemiaS Killick
Department of Haematology, St George s Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK
Haematologica 84:699-706. 1999..We present the first comprehensive study analyzing induction and consolidation therapy of biphenotypic leukemia and correlate outcome to prognostic factors...
- Acute erythroid leukemia (M6): outcome of bone marrow transplantationS Killick
Leukaemia Unit, The Royal Marsden NHS Trust and Institute of Cancer Research, London, UK
Leuk Lymphoma 35:99-107. 1999..The disease is sensitive to AML induction regimens and long-term survival can be achieved with BMT in first complete remission...
- Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interactionS B Killick
Department of Haematology, St George s Hospital Medical School, London, UK
Br J Haematol 111:1164-9. 2000..Finally, we have shown that in vivo ATG treatment reduced the expression of Fas-ag on AA BM CD34(+) cells...
- Reduced TGF-beta1 in patients with aplastic anaemia in vivo and in vitroS Rizzo
Department of Haematology, St George s Hospital Medical School, London
Br J Haematol 107:797-803. 1999....
- The effect of treatment with Campath-1H in patients with autoimmune cytopeniasF Willis
Department of Haematology, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
Br J Haematol 114:891-8. 2001..Fourteen patients are alive at a median of 12 months (range 4-61) after Campath-1H. Campath-1H represents an alternative therapeutic option for severe, refractory autoimmune cytopenias...